In line with these clinical data, the non-seminoma derived NT2D1 cells exhibit the highest sensitivity to HGF administration: these cells respond to HGF increasing their malignant behaviour in terms of proliferation, chemo-attraction and invasiveness [21]. This evidence concerns the gene HGF and seminoma.